News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Drugmaker Merck & Co., Inc. (JOBS) Posts 12 Percent Drop In 2Q Profit
July 21, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP) -- Drugmaker Merck & Co. on Tuesday posted a 12 percent drop in second-quarter profit, due to lower sales of its cholesterol drugs and several vaccines, but still beat Wall Street's conservative expectations.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Merck & Co.
MORE ON THIS TOPIC
Mergers & acquisitions
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms
March 25, 2026
·
3 min read
·
Tristan Manalac
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
March 25, 2026
·
2 min read
·
Tristan Manalac
Podcast
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
March 25, 2026
·
1 min read
·
Heather McKenzie
Manufacturing
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
March 24, 2026
·
2 min read
·
Nick Paul Taylor